Sexual and reproductive health

Carcinogenicity of combined hormonal contraceptives and combined menopausal treatment

Statement

Share

Authors:
UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP)

Carcinogenicity of combined hormonal contraceptives and combined menopausal treatment

Publication details

Number of pages: 2
Publication date: 2005
Languages: English - Web only

Downloads

This statement comes form the June 2005 meeting of experts, convened by the International Agency for Research on Cancer (IARC), to review the scientific evidence on the carcinogenic risks to humans posed by combined estrogen-progestogen oral contraceptives (COCs) and combined estrogen-progestogen hormonal menopausal therapy.